Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I : Epidemiology, virology, pathology and general health issues.
Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I : Epidemiology, virology, pathology and general health issues.
复制标题
严重的急性呼吸综合征(SARS)和GDP。第一部分:流行病学,病毒学,病理学和一般健康问题。
DOI:
10.1038/sj.bdj.4811469
复制
发表时间:
2004-07-24
影响因子:
2.6
通讯作者:
Samaranayake LP
中科院分区:
文献类型:
--
作者:
Li RW;Leung KW;Sun FC;Samaranayake LP
SARS is a highly infectious and rapidly progressive form of atypical pneumonia caused by a newly identified strain of coronavirus (SARS-CoV). Diagnosis is based on clinical findings, epidemiology and exclusion from other pneumonias and is confirmed by a positive seroconversion. There is as yet no definitive treatment protocol. Symptoms may be similar to other less infective or morbid diseases and over one quarter of those affected have been unsuspecting healthcare workers. HCW must be familiar with the clinical features and case definitions of SARS to assist in the screening of the disease and prevention of spread. Surveillance for possible SARS is recommended and control of the epidemic depends on early identification and isolation of carriers and effective infection control and public health measures. The health profession faces a new challenge with the emergence of a novel viral disease Severe Acute Respiratory Syndrome (SARS), a form of atypical pneumonia caused by a coronavirus termed SARS-CoV. This highly infectious disease has spread through 32 countries, infecting more than 8,400 patients with over 790 deaths in just over 6 months. Over one quarter of those infected were unsuspecting healthcare workers. The major transmission mode of SARS-coronavirus appears to be through droplet spread with other minor subsidiary modes of transmission such as close contact and fomites although air borne transmission has not been ruled out. There is as yet no definitive treatment protocol. Although the peak period of the outbreak is likely to have passed and the risk of SARS in the UK is therefore assessed to be low, the World Health Organisation has asked all countries to remain vigilant lest SARS re-emerges. Recent laboratory acquired cases of SARS reported from Taiwan and Beijing, China are a testimony to this risk. Until reliable diagnostic tests, vaccine and medications are available, control of SARS outbreaks depends on close surveillance, early identification of index cases, quick isolation of carriers and effective infection control and public health measures.
登录
查看更多内容
DOI:
10.1016/s0140-6736(03)13077-2
发表时间:
2003-04-19
期刊:
Lancet (London, England)
影响因子:
--
作者:
Peiris JS;Lai ST;Poon LL;Guan Y;Yam LY;Lim W;Nicholls J;Yee WK;Yan WW;Cheung MT;Cheng VC;Chan KH;Tsang DN;Yung RW;Ng TK;Yuen KY;SARS study group
通讯作者:
SARS study group
影响因子:
1.8
作者:
GHOSE, TK
通讯作者:
GHOSE, TK
影响因子:
158.5
作者:
Poutanen, SM;Low, DE;McGeer, AJ
通讯作者:
McGeer, AJ
影响因子:
158.5
作者:
Ksiazek, TG;Erdman, D;Anderson, LJ
通讯作者:
Anderson, LJ
影响因子:
56.9
作者:
Rota, PA;Oberste, MS;Bellini, WJ
通讯作者:
Bellini, WJ